- Home
- CTEV vs QURE Comparison
CTEV vs QURE Comparison
Compare CTEV & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTEV
- QURE
- Stock Information
- Founded
- CTEV 1980
- QURE 1998
- Country
- CTEV United States
- QURE Netherlands
- Employees
- CTEV N/A
- QURE N/A
- Industry
- CTEV
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- CTEV
- QURE Health Care
- Exchange
- CTEV NYSE
- QURE Nasdaq
- Market Cap
- CTEV 661.2M
- QURE 725.4M
- IPO Year
- CTEV N/A
- QURE 2007
- Fundamental
- Price
- CTEV $46.61
- QURE $14.62
- Analyst Decision
- CTEV Buy
- QURE Strong Buy
- Analyst Count
- CTEV 1
- QURE 10
- Target Price
- CTEV $44.00
- QURE $37.20
- AVG Volume (30 Days)
- CTEV 174.4K
- QURE 1.1M
- Earning Date
- CTEV 07-31-2025
- QURE 07-31-2025
- Dividend Yield
- CTEV N/A
- QURE N/A
- EPS Growth
- CTEV N/A
- QURE N/A
- EPS
- CTEV N/A
- QURE N/A
- Revenue
- CTEV $927,446,000.00
- QURE $20,201,000.00
- Revenue This Year
- CTEV $2.40
- QURE N/A
- Revenue Next Year
- CTEV $3.12
- QURE $278.91
- P/E Ratio
- CTEV N/A
- QURE N/A
- Revenue Growth
- CTEV N/A
- QURE 6.30
- 52 Week Low
- CTEV $4.80
- QURE $4.45
- 52 Week High
- CTEV $51.29
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- CTEV N/A
- QURE 50.64
- Support Level
- CTEV N/A
- QURE $14.03
- Resistance Level
- CTEV N/A
- QURE $15.16
- Average True Range (ATR)
- CTEV 0.00
- QURE 0.63
- MACD
- CTEV 0.00
- QURE 0.02
- Stochastic Oscillator
- CTEV 0.00
- QURE 67.88
About CTEV CLARITEV CORPORATION
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.